COPD
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
It recently obtained a 510(k) clearance from the US and funding for its expansion in Southeast Asia.
The virtual cardiopulmonary company told MobiHealthNews exclusively that it has appointed Stacie Bratcher as its CEO.
The wearable device directly measures respiration to predict deterioration in COPD patients.
Also, AI cancer treatment software provider PVMed scores $14M in Series A funding.
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
The latest round follows a $14 million Series B raise from 2019.
The immersive cardiac rehabilitation app, myHeart uses behavioural feedback and gamification to improve heart health.
The digital therapeutics company plans to expand its services in the US and Europe.